215 Update of open-label extension study evaluating the long-term safety and efficacy of romiplostim in thrombocytopenic patients with myelodysplastic syndromes (MDS)

Journal article

Peer reviewed

P. Fenaux, H. Kantarjian, R.M. Lyons, R.A. Larson, M.A. Sekeres, P.S. Becker, P. Muus, C. Jia and A.S. Yang

Leukemia research, Vol.35, pp.S84-S84

2011-05

Metrics

6 Record Views

Title: 215 Update of open-label extension study evaluating the long-term safety and efficacy of romiplostim in thrombocytopenic patients with myelodysplastic syndromes (MDS)
Creators: P. Fenaux
H. Kantarjian
R.M. Lyons
R.A. Larson
M.A. Sekeres
P.S. Becker
P. Muus
C. Jia
A.S. Yang
Publication Details: Leukemia research, Vol.35, pp.S84-S84
Academic Unit: UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031757822302976